MADYSN CIERI: Open Payments
NPI 1861184749 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 11 payments from 9 companies in 2025. Trend: 2023 $454 · 2024 $258 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $188 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Pharmacosmos Therapeutics Inc. | 1 | $145 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Grifols USA, LLC | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $111 |
Products named: Kerendia, REZDIFFRA, MONOFERRIC, VOQUEZNA, KRYSTEXXA, Prolastin-C Liquid, Symbravo, Ozempic.
Industry payments across NY — which companies pay providers there.
